• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在N-保护氨基酸的(3H-喹唑啉-4-亚基)酰肼及其杂环化产物中定向搜索抗炎剂。

Directed Search of Anti-inflammatory Agents Among (3HQuinazoline- 4-ylidene)hydrazides of N-protected Amino acids and their Heterocyclization Products.

作者信息

Martynenko Yulya, Antypenko Oleksii, Nosulenko Inna, Berest Galina, Kovalenko Sergii

机构信息

Department of Organic and Bioorganic Chemistry, Pharmaceutical Faculty No. 2, Zaporizhzhia State Medical University, Zaporizhzhia, Ukraine.

Department of Pharmacognosy with the Course of Botany, Pharmaceutical Faculty No. 2, Zaporizhzhia State Medical University, Zaporizhzhia, Ukraine.

出版信息

Antiinflamm Antiallergy Agents Med Chem. 2020;19(1):61-73. doi: 10.2174/1871523018666190115092215.

DOI:10.2174/1871523018666190115092215
PMID:30648525
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7460736/
Abstract

BACKGROUND

(Quinazoline-4-ylidene)hydrazides are valued intermediates in modern organic chemistry, as they are commonly used for the synthesis of substituted [1,2,4]triazolo[1,5-c]quinazolines.

OBJECTIVE

Unknown N-acyl-2-([1,2,4]triazolo[1,5-c]quinazoline-2-yl)-alkyl-(alkaryl-, aryl-) amines were synthesized and evaluated for anti-inflammatory potential.

METHODS

The peculiarities of the synthesized compounds structures were studied by IR-, NMR spectroscopy and chromatography-mass spectrometry and were discussed in detail. Probable molecular mechanisms of activity (inhibition of COX-1 and COX-2) were predicted due to molecular docking. Anti-inflammatory activity of synthesized compounds was determined by their ability to reduce the formalin-induced paw edema in rats. Diclofenac sodium was used as reference drug.

RESULTS

In this study, the synthesis of N-acetyl-(benzoyl)-2-([1,2,4]triazolo[1,5-c]quinazolinе- 2-yl)alkyl-(aralkyl-, aryl-)amines, using (3H-quinazoline-4-ylidene)hydrazides of Nprotected amino acids or 4-hydrazinoquinazoline and N-prorotected amino acids as starting compounds was developed. It was established that the reaction of (3H-quinazoline-4- ylidene)hydrazides of Boc-amino acids occurred with the formation of N-acetyl-substituted triazoloquinazolines. High anti-inflammatory activity was detected for unknown (3Hquinazoline- 4-ylidene)hydrazides Boc-amino acids (1.13-1.15) and N-acetyl-(benzoyl)-2- ([1,2,4]triazolo[1,5-c]quinazoline-2-yl-)aralkyl-(aryl-)amines (3.2, 3.3, 3.11, 3.12), using the experimental formalin test.

CONCLUSION

The conducted SAR-analysis allowed to detect critical fragments. Namely, the Boc-aminoaralkyl-(aryl-)acid residue in (3H-quinazoline-4-ylidene)hydrazides (1.13- 1.15), benzyl and phenyl linker groups in N-acetyl-(benzoyl)-2-([1,2,4]triazolo[1,5- c]quinazoline-2-yl-)aralkyl-(aryl-) amines (3.2, 3.3, 3.11, 3.12) are believed to be substantial for anti-inflammatory activity.

摘要

背景

(喹唑啉-4-亚基)酰肼是现代有机化学中有价值的中间体,因为它们常用于合成取代的[1,2,4]三唑并[1,5-c]喹唑啉。

目的

合成未知的N-酰基-2-([1,2,4]三唑并[1,5-c]喹唑啉-2-基)-烷基-(烷芳基、芳基)胺,并评估其抗炎潜力。

方法

通过红外光谱、核磁共振光谱和色谱-质谱研究了合成化合物结构的特点,并进行了详细讨论。通过分子对接预测了可能的活性分子机制(COX-1和COX-2的抑制)。通过合成化合物减少大鼠福尔马林诱导的爪肿胀的能力来测定其抗炎活性。双氯芬酸钠用作参考药物。

结果

在本研究中,开发了以N-保护氨基酸的(3H-喹唑啉-4-亚基)酰肼或4-肼基喹唑啉和N-保护氨基酸为起始化合物合成N-乙酰基-(苯甲酰基)-2-([1,2,4]三唑并[1,5-c]喹唑啉-2-基)-烷基-(芳烷基、芳基)胺的方法。确定了Boc-氨基酸的(3H-喹唑啉-4-亚基)酰肼反应生成N-乙酰基取代的三唑并喹唑啉。使用实验性福尔马林试验检测到未知的Boc-氨基酸(3H-喹唑啉-4-亚基)酰肼(1.13-1.15)和N-乙酰基-(苯甲酰基)-2-([1,2,4]三唑并[1,5-c]喹唑啉-2-基)-芳烷基-(芳基)胺(3.2、3.3、3.11、3.12)具有高抗炎活性。

结论

进行的构效关系分析允许检测关键片段。即,(3H-喹唑啉-4-亚基)酰肼中的Boc-氨基芳烷基-(芳基)酸残基(1.13-1.15),N-乙酰基-(苯甲酰基)-2-([1,2,4]三唑并[1,5-c]喹唑啉-2-基)-芳烷基-(芳基)胺中的苄基和苯基连接基团(3.2、3.3、3.11、3.12)被认为对抗炎活性至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e962/7460736/99d498ac8f9d/AIAAMC-19-61_F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e962/7460736/291e5d160fb3/AIAAMC-19-61_S1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e962/7460736/99d498ac8f9d/AIAAMC-19-61_F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e962/7460736/291e5d160fb3/AIAAMC-19-61_S1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e962/7460736/99d498ac8f9d/AIAAMC-19-61_F1.jpg

相似文献

1
Directed Search of Anti-inflammatory Agents Among (3HQuinazoline- 4-ylidene)hydrazides of N-protected Amino acids and their Heterocyclization Products.在N-保护氨基酸的(3H-喹唑啉-4-亚基)酰肼及其杂环化产物中定向搜索抗炎剂。
Antiinflamm Antiallergy Agents Med Chem. 2020;19(1):61-73. doi: 10.2174/1871523018666190115092215.
2
Synthesis and Anticancer Activity of 2-(Alkyl-, Alkaryl-, Aryl-, Hetaryl-)-[1,2,4]triazolo[1,5-c]quinazolines.2-(烷基-、烷芳基-、芳基-、杂芳基-)-[1,2,4]三唑并[1,5-c]喹唑啉的合成及其抗癌活性
Sci Pharm. 2013 Apr-Jun;81(2):359-91. doi: 10.3797/scipharm.1211-08. Epub 2012 Dec 23.
3
Quinazoline-containing Hydrazydes of Dicarboxylic Acids and Products of Their Structural Modification: A Novel Class of Anti-inflammatory Agents.含喹唑啉的二羧酸酰肼及其结构修饰产物:一类新型的抗炎药。
Acta Chim Slov. 2021 Jun;68(2):395-403.
4
Directed Search of Biologically Active Compounds among Hydrogenated Isoindolylalkyl(alkylaryl-,aryl-)carboxylic Acids with Quinazoline Fragment that Modify the Carbohydrate Metabolism: Design, Synthesis and Modification.
Acta Chim Slov. 2019 Feb;66(1):145-154.
5
5+1-Heterocyclization as preparative approach for carboxy-containing triazolo[1,5-c]quinazolines with anti-inflammatory activity.5+1-杂环化反应作为一种制备含有羧基的三唑并[1,5-c]喹唑啉的方法,具有抗炎活性。
Eur J Med Chem. 2024 Feb 15;266:116137. doi: 10.1016/j.ejmech.2024.116137. Epub 2024 Jan 11.
6
Substituted 3-R-2,8-Dioxo-7,8-dihydro-2H-pyrrolo[1,2-a][1,2,4] triazino [2,3-c]quinazoline-5a(6H)carboxylic Acids and their Salts - a Promising Class of Anti-inflammatory Agents.取代的 3-R-2,8-二氧代-7,8-二氢-2H-吡咯[1,2-a][1,2,4]三嗪并[2,3-c]喹唑啉-5a(6H)-羧酸及其盐类 - 一类有前途的抗炎剂。
Antiinflamm Antiallergy Agents Med Chem. 2021;20(1):75-88. doi: 10.2174/1871523019666200505073232.
7
Synthesis of Novel Aryl (4-Aryl-1H-Pyrrol-3-yl) (Thiophen-2-yl) Methanone Derivatives: Molecular Modelling, In Silico ADMET, Anti-Inflammatory and Anti-Ulcer Activities.新型芳基(4-芳基-1H-吡咯-3-基)(噻吩-2-基)甲酮衍生物的合成:分子建模、计算机 ADMET、抗炎和抗溃疡活性。
Antiinflamm Antiallergy Agents Med Chem. 2021;20(2):182-195. doi: 10.2174/1871523019999201116191622.
8
Design, Synthesis, and Photophysical Properties of 5-Aminobiphenyl Substituted [1,2,4]Triazolo[4,3-]- and [1,2,4]Triazolo[1,5-]quinazolines.5-氨基联苯取代的[1,2,4]三唑并[4,3-]和[1,2,4]三唑并[1,5-]喹唑啉的设计、合成及光物理性质
Molecules. 2024 May 24;29(11):2497. doi: 10.3390/molecules29112497.
9
Synthesis of Anti-Inflammatory Spirostene-Pyrazole Conjugates by a Consecutive Multicomponent Reaction of Diosgenin with Oxalyl Chloride, Arylalkynes and Hydrazines or Hydrazones.薯蓣皂苷元与草酰氯、芳基炔和肼或腙的连续多组分反应合成抗炎螺甾-吡唑化合物。
Molecules. 2021 Dec 28;27(1):162. doi: 10.3390/molecules27010162.
10
Reactivity of 2-ethoxyquinazolin- 4-yl hydrazine and its use in synthesis of novel quinazoline derivatives of antimicrobial activity.2-乙氧基喹唑啉-4-基肼的反应活性及其在具有抗菌活性的新型喹唑啉衍生物合成中的应用。
Glob J Health Sci. 2011 Dec 29;4(1):174-83. doi: 10.5539/gjhs.v4n1p174.

引用本文的文献

1
Recyclable Magnetic Cu-MOF-74-Catalyzed C(sp)-N Coupling and Cyclization under Microwave Irradiation: Synthesis of Imidazo[1,2-]quinazolines and Their Analogues.可回收磁性Cu-MOF-74催化的微波辐射下C(sp)-N偶联和环化反应:咪唑并[1,2-]喹唑啉及其类似物的合成
ACS Omega. 2023 Apr 25;8(18):16218-16227. doi: 10.1021/acsomega.3c00680. eCollection 2023 May 9.
2
Synthesis, X-ray Structure, Hirshfeld, DFT and Biological Studies on a Quinazolinone-Nitrate Complex.合成、X 射线结构、希夫氏表面分析、DFT 及喹唑啉酮-硝酸盐配合物的生物学研究。
Molecules. 2022 Feb 6;27(3):1089. doi: 10.3390/molecules27031089.
3
2-[(3-Aminoalkyl-(alkaryl-,aryl-))-H-1,2,4-triazol-5-yl]anilines: synthesis and anticonvulsant activity.

本文引用的文献

1
Synthesis and molecular docking studies of xanthone attached amino acids as potential antimicrobial and anti-inflammatory agents.作为潜在抗菌和抗炎剂的氧杂蒽酮连接氨基酸的合成及分子对接研究
Medchemcomm. 2017 Jul 26;8(8):1706-1719. doi: 10.1039/c7md00209b. eCollection 2017 Aug 1.
2
Quinazolines: new horizons in anticonvulsant therapy.喹唑啉类化合物:抗惊厥治疗的新领域。
Eur J Med Chem. 2014 Jun 10;80:447-501. doi: 10.1016/j.ejmech.2014.04.072. Epub 2014 Apr 28.
3
Recent advances in the structural library of functionalized quinazoline and quinazolinone scaffolds: synthetic approaches and multifarious applications.
Turk J Chem. 2020 Jun 1;44(3):746-755. doi: 10.3906/kim-2002-24. eCollection 2020.
功能化喹唑啉和喹唑酮结构库的最新进展:合成方法和多样化的应用。
Eur J Med Chem. 2014 Apr 9;76:193-244. doi: 10.1016/j.ejmech.2014.02.005. Epub 2014 Feb 7.
4
Synthesis and Anticancer Activity of 2-(Alkyl-, Alkaryl-, Aryl-, Hetaryl-)-[1,2,4]triazolo[1,5-c]quinazolines.2-(烷基-、烷芳基-、芳基-、杂芳基-)-[1,2,4]三唑并[1,5-c]喹唑啉的合成及其抗癌活性
Sci Pharm. 2013 Apr-Jun;81(2):359-91. doi: 10.3797/scipharm.1211-08. Epub 2012 Dec 23.
5
Reactivity of 2-ethoxyquinazolin- 4-yl hydrazine and its use in synthesis of novel quinazoline derivatives of antimicrobial activity.2-乙氧基喹唑啉-4-基肼的反应活性及其在具有抗菌活性的新型喹唑啉衍生物合成中的应用。
Glob J Health Sci. 2011 Dec 29;4(1):174-83. doi: 10.5539/gjhs.v4n1p174.
6
Synthesis, anti-inflammatory activity and molecular docking studies of 2,5-diarylfuran amino acid derivatives.2,5-二芳基呋喃氨基酸衍生物的合成、抗炎活性及分子对接研究。
Eur J Med Chem. 2012 Jan;47(1):52-8. doi: 10.1016/j.ejmech.2011.10.018. Epub 2011 Oct 20.
7
Triazoloquinazolines as a novel class of phosphodiesterase 10A (PDE10A) inhibitors.三唑并喹唑啉类化合物作为新型磷酸二酯酶 10A(PDE10A)抑制剂。
Bioorg Med Chem Lett. 2011 Jun 15;21(12):3738-42. doi: 10.1016/j.bmcl.2011.04.067. Epub 2011 Apr 30.
8
AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading.AutoDock Vina:通过新的评分函数、高效优化和多线程改进对接的速度和准确性。
J Comput Chem. 2010 Jan 30;31(2):455-61. doi: 10.1002/jcc.21334.
9
Synthesis and evaluation of adenosine antagonist activity of a series of [1,2,4]triazolo[1,5-c]quinazolines.一系列[1,2,4]三唑并[1,5-c]喹唑啉的腺苷拮抗剂活性的合成与评价
Chem Pharm Bull (Tokyo). 2007 Mar;55(3):372-5. doi: 10.1248/cpb.55.372.
10
Facile synthesis of fused 1,2,4-triazolo[1,5-c]pyrimidine derivatives as human adenosine A3 receptor ligands.作为人腺苷A3受体配体的稠合1,2,4-三唑并[1,5-c]嘧啶衍生物的简便合成
Bioorg Med Chem Lett. 2004 May 17;14(10):2443-6. doi: 10.1016/j.bmcl.2004.03.010.